131 related articles for article (PubMed ID: 1713804)
1. Elevation of circulating immune complexes and its relationship to alpha-fetoprotein levels in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY; Ton TC
Cancer Invest; 1991; 9(2):137-43. PubMed ID: 1713804
[TBL] [Abstract][Full Text] [Related]
2. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
Tsai JF; Tsai JH; Chang WY
Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Lin ZY; Tsai JH
Br J Cancer; 1995 Aug; 72(2):442-6. PubMed ID: 7543774
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
5. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
[TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein synthesis in human hepatocellular carcinoma: correlation with hepatitis B surface antigen expression.
Kashala LO; Kalengayi MM; Essex M
Cancer Invest; 1992; 10(6):513-22. PubMed ID: 1384940
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma.
Liaw YF; Tai DI; Chen TJ; Chu CM; Huang MJ
Liver; 1986 Jun; 6(3):133-7. PubMed ID: 2427909
[TBL] [Abstract][Full Text] [Related]
9. HLA antigen in Chinese patients with hepatocellular carcinomas.
Chan SH; Simons MJ; Oon CJ
J Natl Cancer Inst; 1980 Jul; 65(1):21-3. PubMed ID: 6156260
[TBL] [Abstract][Full Text] [Related]
10. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
11. Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis.
Akuta N; Suzuki F; Kobayashi M; Hara T; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
J Med Virol; 2014 Jan; 86(1):131-8. PubMed ID: 24123090
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Nagashima H; Tsuji T
Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
14. A serological study on primary hepatocellular carcinoma in Zambia.
Zumla A; Voller A
Trans R Soc Trop Med Hyg; 1982; 76(4):546-51. PubMed ID: 6190277
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of transiently elevated serum AFP level in developing hepatocellular carcinoma in HBsAg positive-liver cirrhosis].
Lee HY; Jung JH; Kang YS; Kim YS; Moon HS; Park KO; Lee YS; Kim SM; Seo SW; Lee SW; Kim SH; Lee BS; Kim NJ
Korean J Gastroenterol; 2004 Apr; 43(4):252-9. PubMed ID: 15100489
[TBL] [Abstract][Full Text] [Related]
16. Alphafetoprotein levels of liver cancer patients and controls in a European population.
Trichopoulos D; Sizaret P; Tabor E; Gerety RJ; Martel N; Munoz N; Theodoropoulos G
Cancer; 1980 Aug; 46(4):736-40. PubMed ID: 6156754
[TBL] [Abstract][Full Text] [Related]
17. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
Stránský J; Zichová M; Vodák M
Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
[TBL] [Abstract][Full Text] [Related]
18. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
19. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study.
McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J
Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632
[TBL] [Abstract][Full Text] [Related]
20. [Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma].
Du J; Tian P; Chen TY; Wu JX; Wang JB; Wei Y; Wang LM; Liu LG; Ji WS; Qu CF
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):905-10. PubMed ID: 22340099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
